It is currently Thu May 28, 2015 1:29 pm
Carl Icahn raises the stakes for Big Pharma
The financier has set a high benchmark for bidders for the biotech firm. Fortune's John Simons explains why Big Pharma is likely to pay top dollar for a very risky asset.
Total posts 225651 • Total topics 23669 • Total members 15023